Carisbamate Completed Phase 2 Trials for Diabetic Mononeuropathy / Diabetic Polyneuropathy / Painful Diabetic Neuropathy (PDN) / Neuralgia, Diabetic Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00501202Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).